A malaria vaccine adjuvant based on recombinant antigen binding to liposomes

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications

van Rooijen, N., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,763 · see citing works

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070 · see citing works

The origin and development of nonlymphoid tissue CD103+ DCs

Ginhoux, F., Liu, K., Helft, J., Bogunovic, M., Greter, M., Hashimoto, D., Price, J. G., Yin, N., Bromberg, J. S., Lira, S. A., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091756 · Cited by 736 · see citing works

Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells

Edelson, B. T., Wumesh, K. C., Juang, R., Kohyama, M., Benoît, L. A., Klekotka, P. A., Moon, C., Albring, J. C., Ise, W., Michael, D. G., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091627 · Cited by 710 · see citing works

Effective Treatment of Cobalamin Deficiency With Oral Cobalamin

Kuzminski, A. M., Giacco, E. J. D., Allen, R. H., Stabler, S. P., & Lindenbaum, J. (1998) · Blood · doi:10.1182/blood.v92.4.1191 · Cited by 461 · see citing works

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Wu, Y., Ellis, R. D., Shaffer, D., Fontes, E., Malkin, E. M., Mahanty, S., Fay, M. P., Narum, D. L., Rausch, K. M., Miles, A. P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002636 · Cited by 447 · see citing works

Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes

Calabrό, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., Gregorio, E. D., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 431 · see citing works

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

Brune, K. D., Leneghan, D. B., Brian, I. J., Ishizuka, A. S., Bachmann, M. F., Draper, S. J., Biswas, S., & Howarth, M. R. (2016) · Scientific Reports · doi:10.1038/srep19234 · Cited by 415 · see citing works

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

Kaslow, D. C., Quakyi, I. A., Syin, C., Raum, M. G., Keister, D. B., Coligan, J. E., McCutchan, T. F., & Miller, L. H. (1988) · Nature · doi:10.1038/333074a0 · Cited by 374 · see citing works

Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size

Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. ‐. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 344 · see citing works

Integral membrane protein located in the apical complex of Plasmodium falciparum.

PETERSON, M. G., Marshall, V. M., Smythe, J. A., Crewther, P. E., Lew, A. M., Silva, A., Anders, R. F., & Kemp, D. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3151 · Cited by 244 · see citing works

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

Malkin, E. M., Durbin, A. P., Diemert, D. J., Sattabongkot, J., Wu, Y., Miura, K., Long, C. A., Lambert, L., Miles, A. P., Wang, J., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.12.019 · Cited by 237 · see citing works

Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

Miura, K., Orcutt, A. C., Muratova, O. V., Miller, L. H., Saul, A. J., & Long, C. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.064 · Cited by 228 · see citing works

Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.

Barr, P. J., Green, K. M., Gibson, H. L., Bathurst, I., Quakyi, I. A., & Kaslow, D. C. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.5.1203 · Cited by 222 · see citing works

Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake

Liang, F., Lindgren, G., Sandgren, K. J., Thompson, E. A., Francica, J. R., Seubert, A., Gregorio, E. D., Barnett, S. W., O’Hagan, D. T., Sullivan, N. J., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2094 · Cited by 206 · see citing works

The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.

Quakyi, I. A., Carter, R., Rener, J. C., Kumar, N., Good, M. F., & Miller, L. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4213 · Cited by 195 · see citing works

Disposable electrochemical immunosensor for carcinoembryonic antigen using ferrocene liposomes and MWCNT screen-printed electrode

Viswanathan, S., Rani, C., Anand, A. V., & Ho, J. A. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.10.006 · Cited by 167 · see citing works

Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens

Fan, Y., Sahdev, P., Ochyl, L. J., Akerberg, J. J., & Moon, J. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.010 · Cited by 159 · see citing works

Functionalization of cobalt porphyrin–phospholipid bilayers with his-tagged ligands and antigens

Shao, S., Geng, J., Yi, H., Gogia, S., Neelamegham, S., Jacobs, A., & Lovell, J. F. (2015) · Nature Chemistry · doi:10.1038/nchem.2236 · Cited by 159 · see citing works

Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission

Gregory, J. A., Li, F., Tomosada, L. M., Cox, C., Topol, A. B., Vinetz, J. M., & Mayfield, S. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037179 · Cited by 139 · see citing works

Alga-Produced Cholera Toxin-Pfs25 Fusion Proteins as Oral Vaccines

Gregory, J. A., Topol, A. B., Doerner, D. Z., & Mayfield, S. P. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00714-13 · Cited by 132 · see citing works

Hydroxocobalamin: Improved public health readiness for cyanide disasters

Sauer, S. W., & Keim, M. E. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.114315 · Cited by 126 · see citing works

A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice

Jones, R. M., Chichester, J. A., Mett, V. L., Jaje, J., Tottey, S., Manceva, S. D., Casta, L. J., Gibbs, S. K., Musiychuk, K., Shamloul, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079538 · Cited by 117 · see citing works

Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum

Kaslow, D. C., Bathurst, I., Lensen, T. H. W., Ponnudurai, T., Barr, P. J., & Keister, D. B. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5576-5580.1994 · Cited by 115 · see citing works

Plasmacytoid, conventional, and monocyte‐derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation

Manh, T. V., Alexandre, Y. O., Baranek, T., Crozat, K., & Dalod, M. (2013) · European Journal of Immunology · doi:10.1002/eji.201243106 · Cited by 114 · see citing works

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

Doolan, D. L., & Hoffman, S. L. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00184-9 · Cited by 107 · see citing works

Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle

Shimp, R. L., Rowe, C. G., Reiter, K., Chen, B., Nguyen, V., Aebig, J. A., Rausch, K. M., Kumar, K., Wu, Y., Jin, A. J., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.04.034 · Cited by 100 · see citing works

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology

Li, Y., Leneghan, D. B., Miura, K., Nikolaeva, D., Brian, I. J., Dicks, M. D. J., Fyfe, A. J., Zakutansky, S. E., de Cassan, S., Long, C. A., et al. (2016) · Scientific Reports · doi:10.1038/srep18848 · Cited by 98 · see citing works

Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

Kumar, R., Ray, P. C., Datta, D., Bansal, G. P., Angov, E., & Kumar, N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.08.025 · Cited by 97 · see citing works

High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model

Dutta, S., Sullivan, J. S., Grady, K. K., Haynes, J. D., Komisar, J. L., Batchelor, A. H., Soisson, L. A., Diggs, C. L., Heppner, D. G., Lanar, D. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008138 · Cited by 93 · see citing works

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward

Nunes, J. K., Woods, C., Carter, T., Raphael, T., Morin, M. J., Diallo, D. A., Leboulleux, D., Jain, S. K., Loucq, C., Kaslow, D. C., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.030 · Cited by 85 · see citing works

Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses

Bale, S., Goebrecht, G. K. E., Stano, A., Wilson, R., Ota, T., Tran, K., Ingale, J., Zwick, M. B., & Wyatt, R. T. (2017) · Journal of Virology · doi:10.1128/jvi.00443-17 · Cited by 75 · see citing works

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25

Scally, S. W., McLeod, B., Bosch, A., Miura, K., Liang, Q., Carroll, S., Reponen, S., Nguyen, T. K. N., Giladi, E., Rämisch, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01924-3 · Cited by 72 · see citing works

Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21

Beck, Z., Matyas, G. R., Jalah, R., Rao, M., Polonis, V. R., & Alving, C. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.001 · Cited by 70 · see citing works

Integral Membrane Protein Located in the Apical Complex of Plasmodium falciparum

PETERSON, M. G., Marshall, V. M., Smythe, J. A., Crewther, P. E., Lew, A. M., Silva, A., Anders, R. F., & Kemp, D. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3151-3154.1989 · Cited by 70 · see citing works

Antibodies to plant-producedPlasmodium falciparumsexual stage protein Pfs25 exhibit transmission blocking activity

Farrance, C. E., Chichester, J. A., Musiychuk, K., Shamloul, M., Rhee, A., Manceva, S. D., Jones, R. M., Mamedov, T., Sharma, S., Mett, V. L., et al. (2011) · Human Vaccines · doi:10.4161/hv.7.0.14588 · Cited by 66 · see citing works

Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013

Genito, C. J., Beck, Z., Phares, T. W., Kalle, F., Limbach, K. J., Stefaniak, M. E., Patterson, N. B., Bergmann‐Leitner, E. S., Waters, N. C., Matyas, G. R., et al. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.070 · Cited by 62 · see citing works

Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate

Radtke, A. J., Anderson, C. F., Riteau, N., Rausch, K. M., Scaria, P. V., Kelnhofer, E., Howard, R. F., Sher, A., Germain, R. N., & Duffy, P. E. (2017) · Scientific Reports · doi:10.1038/srep40312 · Cited by 59 · see citing works

The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species

Cheru, L., Wu, Y., Diouf, A., Moretz, S. E., Muratova, O. V., Song, G., Fay, M. P., Miller, L. H., Long, C. A., & Miura, K. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.036 · Cited by 57 · see citing works

Status of vaccine research and development of vaccines for malaria

Birkett, A. J. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.074 · Cited by 57 · see citing works

Potent Malaria Transmission-Blocking Antibody Responses Elicited by Plasmodium falciparum Pfs25 Expressed in Escherichia coli after Successful Protein Refolding

Kumar, R., Angov, E., & Kumar, N. (2014) · Infection and Immunity · doi:10.1128/iai.01438-13 · Cited by 55 · see citing works

Expression of early gametocyte-stage antigens Pfg27 and Pfs16 in synchronized gametocytes and non-gametocyte producing clones of Plasmodium falciparum

Lobo, C.-A., Ruud, N. H., Konings, & Kumar, N. (1994) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(94)00155-3 · Cited by 53 · see citing works

A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity

Goodman, A. L., Blagborough, A. M., Biswas, S., Wu, Y., Hill, A. V. S., Sinden, R. E., & Draper, S. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029428 · Cited by 53 · see citing works

Influence of Multivalent Nitrilotriacetic Acid Lipid−Ligand Affinity on the Circulation Half-Life in Mice of a Liposome-Attached His6-Protein

Platt, V. M., Huang, Z. R., Cao, L., Tiffany, M. R., Riviere, K., & Szoka, F. C. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900448f · Cited by 49 · see citing works

Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen

Mlambo, G., Kumar, N., & Yoshida, S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.022 · Cited by 46 · see citing works

Plasmodium vivax Ookinete Surface Protein Pvs25 Linked to Cholera Toxin B Subunit Induces Potent Transmission-Blocking Immunity by Intranasal as Well as Subcutaneous Immunization

Miyata, T., Harakuni, T., Tsuboi, T., Sattabongkot, J., Kohama, H., Tachibana, M., Matsuzaki, G., Torii, M., & Arakawa, T. (2010) · Infection and Immunity · doi:10.1128/iai.00306-10 · Cited by 43 · see citing works

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

Lee, S., Wu, C., Plieskatt, J. L., McAdams, D. H., Miura, K., Ockenhouse, C. F., & King, C. R. (2016) · Malaria Journal · doi:10.1186/s12936-016-1464-6 · Cited by 40 · see citing works

N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate

Lee, S., Wu, C., Plieskatt, J. L., Miura, K., Hickey, J. M., & King, C. R. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00140-17 · Cited by 35 · see citing works

In vitro characterization of binding and stability of single-chain Fv Ni-NTA-liposomes

Rüger, R., Müller, D., Fahr, A., & Kontermann, R. E. (2006) · Journal of drug targeting · doi:10.1080/10611860600864018 · Cited by 23 · see citing works

Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles

Kumar, R., Ledet, G. A., Graves, R. A., Datta, D., Robinson, S., Bansal, G. P., Mandal, T. K., & Kumar, N. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1743-x · Cited by 20 · see citing works

Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate

Lee, S., Plieskatt, J. L., & King, C. R. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.11.009 · Cited by 13 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology

Cheng, K., Zhao, R., Li, Y., Qi, Y., Wang, Y., Zhang, Y., Qin, H., Qin, Y., Chen, L., Li, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22308-8 · Cited by 480 · see citing works

Second Near‐Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy

Li, J., Yu, X., Jiang, Y., He, S., Zhang, Y., Luo, Y., & Pu, K. (2020) · Advanced Materials · doi:10.1002/adma.202003458 · Cited by 342 · see citing works

Organic Semiconducting Pro‐nanostimulants for Near‐Infrared Photoactivatable Cancer Immunotherapy

Li, J., Cui, D. M., Huang, J., He, S., Yang, Z., Zhang, Y., Luo, Y., & Pu, K. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201906288 · Cited by 304 · see citing works

Controlling timing and location in vaccines

Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 251 · see citing works

Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health

Fries, C. N., Curvino, E. J., Chen, J., Permar, S. R., Fouda, G. G., & Collier, J. H. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0739-9 · Cited by 246 · see citing works

Materials for Immunotherapy

Shields, C. W., Wang, L., Evans, M. A., & Mitragotri, S. (2019) · Advanced Materials · doi:10.1002/adma.201901633 · Cited by 190 · see citing works

Vaccine delivery systems toward lymph nodes

Ding, Y., Li, Z., Jaklenec, A., & Hu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113914 · Cited by 189 · see citing works

Advancements in prophylactic and therapeutic nanovaccines

Bhardwaj, P., Bhatia, E., Sharma, S., Ahamad, N., & Banerjee, R. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.020 · Cited by 155 · see citing works

Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy

Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R., & Lin, W. (2024) · Advanced Science · doi:10.1002/advs.202310309 · Cited by 142 · see citing works

Emerging vaccine nanotechnology: From defense against infection to sniping cancer

Feng, C., Li, Y., Ferdows, B. E., Patel, D. N., Ouyang, J., Tang, Z., Kong, N., Chen, E., & Tao, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.021 · Cited by 129 · see citing works

Advances in Infectious Disease Vaccine Adjuvants

Fan, J., Jin, S., Gilmartin, L., Tóth, I., Hussein, W. M., & Stephenson, R. J. (2022) · Vaccines · doi:10.3390/vaccines10071120 · Cited by 114 · see citing works

Ultrasound technology and biomaterials for precise drug therapy

Zhao, Z., Saiding, Q., Cai, Z., Cai, M., & Cai, M. (2023) · Materials Today · doi:10.1016/j.mattod.2022.12.004 · Cited by 108 · see citing works

Liposomes as Adjuvants and Vaccine Delivery Systems

Tretiakova, D. S., & Vodovozova, E. L. (2022) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747822020076 · Cited by 104 · see citing works

SARS‐CoV‐2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination

Huang, W., Zhou, S., He, X., Chiem, K., Mabrouk, M. T., Nissly, R. H., Bird, I. M., Strauss, M., Sambhara, S. R., Ortega, J., et al. (2020) · Advanced Materials · doi:10.1002/adma.202005637 · Cited by 98 · see citing works

Biosynthesis of Self‐Assembled Proteinaceous Nanoparticles for Vaccination

Pan, C., Wu, J., Qing, S., Zhang, X., Zhang, L., Yue, H., Zeng, M., Wang, B., Yuan, Z., Qiu, Y., et al. (2020) · Advanced Materials · doi:10.1002/adma.202002940 · Cited by 93 · see citing works

Use of Protamine in Nanopharmaceuticals—A Review

Ruseska, I., Fresacher, K., Petschacher, C., & Zimmer, A. (2021) · Nanomaterials · doi:10.3390/nano11061508 · Cited by 90 · see citing works

Improving Cancer Immunotherapy Outcomes Using Biomaterials

Yan, S., Luo, Z., Li, Z., Wang, Y., Tao, J., Gong, C., & Liu, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002780 · Cited by 90 · see citing works

Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics

García-Vello, P., Lorenzo, F. D., Zucchetta, D., Zamyatina, A., Castro, C. D., & Molinaro, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107970 · Cited by 83 · see citing works

Photoactivatable Immunostimulatory Nanomedicine for Immunometabolic Cancer Therapy

Wu, W., Pu, Y., Zhou, B., Shen, Y., Gao, S., Zhou, M., & Shi, J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c07872 · Cited by 81 · see citing works

Advanced technologies for the development of infectious disease vaccines

Gupta, A., Rudra, A., Reed, K., Langer, R., & Anderson, D. G. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01041-z · Cited by 85 · see citing works

Metal-based nano-vaccines for cancer immunotherapy

Li, J., Ren, H., & Zhang, Y. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214345 · Cited by 79 · see citing works

A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8+ T Cell Epitopes

He, X., Zhou, S., Huang, W., Seffouh, A., Mabrouk, M. T., Morgan, M. T., Ortega, J., Abrams, S. I., & Lovell, J. F. (2021) · ACS Nano · doi:10.1021/acsnano.0c07680 · Cited by 73 · see citing works

Soft materials as biological and artificial membranes

Tang, S., Davoudi, Z., Wang, G., Xu, Z., Rehman, T. U., Promiński, A., Tian, B., Bratlie, K. M., Peng, H., & Wang, Q. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00029b · Cited by 72 · see citing works

Nanocarrier system: An emerging strategy for bioactive peptide delivery

Zhang, X., Li, X., Zhao, Y., Zheng, Q., Wu, Q., & Yu, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1050647 · Cited by 63 · see citing works

Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria

Gujjari, L., Kalani, H., Pindiprolu, S. K. S. S., Arakareddy, B. P., & Yadagiri, G. (2022) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2022.e00244 · Cited by 58 · see citing works

Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes

Cheng, Z., Que, H., Chen, L., Sun, Q., & Wei, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071372 · Cited by 60 · see citing works

Organic Semiconducting Pro‐nanostimulants for Near‐Infrared Photoactivatable Cancer Immunotherapy

Li, J., Cui, D. M., Huang, J., He, S., Yang, Z., Zhang, Y., Luo, Y., & Pu, K. (2019) · Angewandte Chemie · doi:10.1002/ange.201906288 · Cited by 56 · see citing works

Biomaterials as Tools to Decode Immunity

Eppler, H. B., & Jewell, C. M. (2019) · Advanced Materials · doi:10.1002/adma.201903367 · Cited by 53 · see citing works

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

Huang, W., Deng, B., Seffouh, A., Ortega, J., Long, C. A., Suresh, R. V., He, X., Miura, K., Lee, S., Wu, Y., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0173-x · Cited by 53 · see citing works

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses

McLeod, B., Mabrouk, M. T., Miura, K., Ravichandran, R., Kephart, S. M., Hailemariam, S., Pham, T., Semesi, A., Kucharska, I., Kundu, P., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.015 · Cited by 52 · see citing works

Bioresponsive Immunotherapeutic Materials

Han, J., Sheng, T., Zhang, Y., Cheng, H., Gao, J., Yu, J., & Gu, Z. (2023) · Advanced Materials · doi:10.1002/adma.202209778 · Cited by 51 · see citing works

Vaccine approaches for antigen capture by liposomes

Zhou, S., Luo, Y., & Lovell, J. F. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2274479 · Cited by 49 · see citing works

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants

Lei, H., Alu, A., Yang, J., He, X., He, C., Ren, W., Chen, Z., Hong, W., Chen, L., He, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38066-8 · Cited by 48 · see citing works

Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice

Mabrouk, M. T., Chiem, K., Rujas, E., Huang, W., Jahagirdar, D., Quinn, B., Nair, M. S., Nissly, R. H., Cavener, V. S., Boyle, N. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj1476 · Cited by 47 · see citing works

Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25

McLeod, B., Miura, K., Scally, S. W., Bosch, A., Nguyen, N. T. K., Shin, H., Kim, D., Volkmuth, W., Rämisch, S., Chichester, J. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11980-6 · Cited by 45 · see citing works

Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases

Yenkoidiok-Douti, L., & Jewell, C. M. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01255 · Cited by 42 · see citing works

Liposomes for malaria management: the evolution from 1980 to 2020

Memvanga, P. B., & Nkanga, C. I. (2021) · Malaria Journal · doi:10.1186/s12936-021-03858-0 · Cited by 42 · see citing works

Advanced Materials for SARS‐CoV‐2 Vaccines

Mabrouk, M. T., Huang, W., Martínez‐Sobrido, L., & Lovell, J. F. (2021) · Advanced Materials · doi:10.1002/adma.202107781 · Cited by 38 · see citing works

Long-acting vaccine delivery systems

Walvekar, P., Kumar, P., & Choonara, Y. E. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114897 · Cited by 39 · see citing works

Engineering Biomaterials to Direct Innate Immunity

Oakes, R. S., Froimchuk, E., & Jewell, C. M. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800157 · Cited by 38 · see citing works

Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes

Federizon, J., Frye, A. M., Huang, W., Hart, T. M., He, X., Beltran, C., Marcinkiewicz, A. L., Mainprize, I. L., Wills, M. K. B., Lin, Y., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.10.073 · Cited by 38 · see citing works

HPV‐Associated Tumor Eradication by Vaccination with Synthetic Short Peptides and Particle‐Forming Liposomes

He, X., Zhou, S., Quinn, B., Jahagirdar, D., Ortega, J., Abrams, S. I., & Lovell, J. F. (2021) · Small · doi:10.1002/smll.202007165 · Cited by 37 · see citing works

A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy

Xu, Y., Wang, Y., Yang, Q., Liu, Z., Xiao, Z., Le, Z., Yang, Z., & Yang, C. (2019) · Theranostics · doi:10.7150/thno.34031 · Cited by 37 · see citing works

Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose

Huang, W., Deng, B., Mabrouk, M. T., Seffouh, A., Ortega, J., Long, C. A., Miura, K., Wu, Y., & Lovell, J. F. (2020) · Malaria Journal · doi:10.1186/s12936-020-03368-5 · Cited by 36 · see citing works

A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge

Sia, Z. R., He, X., Zhang, A., Ang, J. C., Shao, S., Seffouh, A., Huang, W., D’Agostino, M. R., Dereshgi, A. T., Sambhara, S. R., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025759118 · Cited by 35 · see citing works

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response

Scaria, P. V., Roth, N., Schwendt, K., Muratova, O. V., Alani, N., Lambert, L., Barnafo, E. K., Rowe, C. G., Zaidi, I., Rausch, K. M., et al. (2024) · npj Vaccines · doi:10.1038/s41541-023-00783-y · Cited by 34 · see citing works

Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective

Pei, Z., Li, L., Yang, N., Sun, S., Jiang, N., & Cheng, L. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215969 · Cited by 34 · see citing works

Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection

Wang, J., Zhang, Y., Jia, Y., Xing, H., Xu, F., Xia, B., Lai, W., Yuan, Y., Li, X., Shan, S., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01343-6 · Cited by 34 · see citing works

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages

Huang, W., Mabrouk, M. T., Zhou, L., Baba, M., Tachibana, M., Torii, M., Takashima, E., Locke, E., Plieskatt, J. L., King, C. R., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03688-z · Cited by 34 · see citing works

A sweeter approach to vaccine design

Wilson, J. T. (2019) · Science · doi:10.1126/science.aav9000 · Cited by 33 · see citing works

Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity

Anamika, J., Vishwakarma, N., Gautam, L., Shrivastava, P., Vyas, S., & Vyas, S. P. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00770-z · Cited by 31 · see citing works

Application of liposomes in the treatment of infectious diseases

Suhaimi, N. A. A., Ahmad, S., Husna, S. M. N., Sarmiento, M. E., Acosta, A., Norazmi, M. N., Ibrahim, J., Mohamud, R., & Kadir, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120734 · Cited by 28 · see citing works

Improving Cancer Immunotherapy Outcomes Using Biomaterials

Yan, S., Luo, Z., Li, Z., Wang, Y., Tao, J., Gong, C., & Liu, X. (2020) · Angewandte Chemie · doi:10.1002/ange.202002780 · Cited by 28 · see citing works

Engineered Nanoparticle Applications for Recombinant Influenza Vaccines

Sia, Z. R., Miller, M. S., & Lovell, J. F. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00383 · Cited by 26 · see citing works

An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice

Shao, S., Huang, W., Lin, C., Hicar, M. D., LaBranche, C. C., Montefiori, D. C., & Lovell, J. F. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02398-8 · Cited by 25 · see citing works

Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability

Mabrouk, M. T., Huang, W., Deng, B., Li-Purcell, N., Seffouh, A., Ortega, J., Atilla‐Gokcumen, G. E., Long, C. A., Miura, K., & Lovell, J. F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119843 · Cited by 24 · see citing works

Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model

He, X., Zhou, S., Dolan, M., Shi, Y., Wang, J., Quinn, B., Jahagirdar, D., Huang, W., Tsuji, M., Пили, Р., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003101 · Cited by 24 · see citing works

Drug‐phospholipid conjugate nano‐assembly for drug delivery

Zhao, D., Zhang, Y., Wang, F., Kaewmanee, R., Cui, W., Wu, T., & Du, Y. (2024) · Smart Medicine · doi:10.1002/smmd.20240053 · Cited by 23 · see citing works

Antigens and adjuvants co-stabilized Pickering emulsions amplify immune responses of subunit vaccines

Guo, Z., Guo, C., Song, Y., He, C., He, P., Wu, F., Tang, X., Xu, Y., Ou, Y., Hu, R., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.009 · Cited by 23 · see citing works

Manganese-Driven Plasmid Nanofibers Formed In Situ for Cancer Gene Delivery and Metalloimmunotherapy

Li, J., Yang, R., Zhang, C., Lovell, J. F., & Zhang, Y. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c18511 · Cited by 21 · see citing works

The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems

Soni, D., Bobbala, S. K. R., Li, S., Scott, E. A., & Dowling, D. J. (2020) · Pediatric Research · doi:10.1038/s41390-020-01112-y · Cited by 21 · see citing works

One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects

Lovell, J. F., Miura, K., Baik, Y. O., Lee, C., Lee, J.-Y., Park, Y.-S., Hong, I., Lee, J. H., Kim, T., Seo, S. H., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.11.004 · Cited by 20 · see citing works

Organic coordination nanoparticles for phototheranostics

Ren, H., Li, J., Lovell, J. F., & Zhang, Y. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215634 · Cited by 20 · see citing works

Imitation of nature: Bionic design in the study of particle adjuvants

Wu, J., & Ma, G. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.004 · Cited by 20 · see citing works

Liposomes for Intra-Articular Analgesic Drug Delivery in Orthopedics: State-of-Art and Future Perspectives. Insights from a Systematic Mini-Review of the Literature

Cipollaro, L., Trucillo, P., Bragazzi, N. L., Porta, G. D., Reverchon, E., & Maffulli, N. (2020) · Medicina · doi:10.3390/medicina56090423 · Cited by 19 · see citing works

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2

Huang, W., Chiem, K., Martínez‐Sobrido, L., & Lovell, J. F. (2022) · Pathogens · doi:10.3390/pathogens11091035 · Cited by 20 · see citing works

A metalloprotein nanoparticle scaffold co-delivers antigens and adjuvants with metal-enhanced STING activation for vaccination preventing viral infections

Li, J., Qiu, Q., Ren, H., Zhang, J., Zhang, C., Liu, G., Sun, B., Zhang, Y., Lovell, J. F., & Zhang, Y. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102156 · Cited by 18 · see citing works

Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association

Federizon, J., Feugmo, C. G. T., Huang, W., He, X., Miura, K., Razi, A., Ortega, J., Karttunen, M., & Lovell, J. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010098 · Cited by 18 · see citing works

Licensed liposomal vaccines and adjuvants in the antigen delivery system

Krasnopolsky, Y., & Pylypenko, D. (2022) · Biotechnologia · doi:10.5114/bta.2022.120709 · Cited by 17 · see citing works

Chromium Nanoparticles Improve Macrophage and T Cell Infiltration for Cancer Immunotherapy

Liu, Q., Sun, Z., Duo, Y., Yin, L., Lv, K., Yue, L., Meng, Q., Nie, D., Chen, J., Luo, D., et al. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.2c01136 · Cited by 17 · see citing works

Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine

Sia, Z. R., Roy, J., Huang, W., Song, Y., Zhou, S., Luo, Y., Li, Q., Arpin, D., Kutscher, H. L., Ortega, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101433 · Cited by 17 · see citing works

Malaria transmission-blocking vaccines: wheat germ cell-free technology can accelerate vaccine development

Miura, K., Tachibana, M., Takashima, E., Morita, M., Kanoi, B. N., Nagaoka, H., Baba, M., Torii, M., Ishino, T., & Tsuboi, T. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1674145 · Cited by 17 · see citing works

Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications

Liang, J., Yao, L., Liu, Z., Chen, Y., Lin, Y., & Tian, T. (2024) · Small · doi:10.1002/smll.202407649 · Cited by 16 · see citing works

Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha

Wetzel, D., Chan, J.-A., Suckow, M., Barbian, A., Weniger, M., Jenzelewski, V., Reiling, L., Richards, J. S., Anderson, D. A., Kouskousis, B. P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221394 · Cited by 16 · see citing works

Advances of Nanotechnology Toward Vaccine Development Against Animal Infectious Diseases

Wang, X., Gao, X., Wang, L., Lin, J., & Liu, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202305061 · Cited by 16 · see citing works

Influenza Virus Infects and Depletes Activated Adaptive Immune Responders

Bohannon, C. D., Ende, Z. S., Cao, W., Mboko, W. P., Ranjan, P., Kumar, A., Mishina, M., Amoah, S., Gangappa, S., Mittal, S. K., et al. (2021) · Advanced Science · doi:10.1002/advs.202100693 · Cited by 15 · see citing works

An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity

He, X., Zhou, S., Quinn, B., Jahagirdar, D., Ortega, J., Long, M. D., Abrams, S. I., & Lovell, J. F. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0332 · Cited by 15 · see citing works

Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus

Sia, Z. R., Chiem, K., Huang, W., Seffouh, A., Dereshgi, A. T., Hogan, T., Ortega, J., Davidson, B. A., Martínez‐Sobrido, L., & Lovell, J. F. (2022) · Journal of Virology · doi:10.1128/jvi.01006-22 · Cited by 15 · see citing works

Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate

Lee, S., Plieskatt, J. L., Krishnan, S., Raina, M., Harishchandra, R., & King, C. R. (2019) · Protein Expression and Purification · doi:10.1016/j.pep.2019.04.001 · Cited by 15 · see citing works

Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants

Li, Z., Chen, P., Qu, A., Sun, M., Xu, L., Xu, C., Hu, S., & Kuang, H. (2025) · Small Methods · doi:10.1002/smtd.202402059 · Cited by 14 · see citing works

Bacillus subtilis spores as delivery system for nasal Plasmodium falciparum circumsporozoite surface protein immunization in a murine model

de Almeida, M. E. M., Alves, K. C. S., de Vasconcelos, M. G. S., Pinto, T. S., Glória, J. C., Chaves, Y. O., Neves, W. L. L., Tarragô, A. M., Neto, J. N. D. S., Astolfi‐Filho, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05344-2 · Cited by 14 · see citing works

Copper indium selenium nanomaterials for photo-amplified immunotherapy through simultaneously enhancing cytotoxic T lymphocyte recruitment and M1 polarization of macrophages

Chen, Y.-N., Yang, Y., He, X., Liu, X., Yu, P., Liu, R., Wei, L., Zhang, B., Zou, T., Liu, H., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.033 · Cited by 13 · see citing works

Mechanochemical insertion of cobalt into porphyrinoids using Co 2 (CO) 8 as a cobalt source

Damunupola, D., Chaudhri, N., Atoyebi, A. O., & Brückner, C. (2020) · Green Chemistry · doi:10.1039/d0gc01010c · Cited by 13 · see citing works

Chloroform-Injection (CI) and Spontaneous-Phase-Transition (SPT) Are Novel Methods, Simplifying the Fabrication of Liposomes with Versatile Solution to Cholesterol Content and Size Distribution

Khan, M. I., Ahmed, N., Umer, M. F., Riaz, A., Ahmad, N. M., & Khan, G. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111065 · Cited by 13 · see citing works

Biomimic strategies for modulating the interaction between particle adjuvants and antigen-presenting cells

Wu, J., & Ma, G. (2020) · Biomaterials Science · doi:10.1039/c9bm02098e · Cited by 13 · see citing works

Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis

Huang, W., EBERLE, K. E., Rosario-Colon, J., Lovell, J. F., & Xin, H. (2024) · mSphere · doi:10.1128/msphere.00189-24 · Cited by 12 · see citing works

A landscape review of malaria vaccine candidates in the pipeline

Tajudeen, Y. A., Oladipo, H. J., Yusuff, S. I., Abimbola, S. O., Abdulkadir, M., Oladunjoye, I. O., Omotosho, A. O., Egbewande, O. M., Shittu, H. D., Yusuf, R. O., et al. (2024) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-024-00222-3 · Cited by 13 · see citing works

A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic activity in an Alzheimer’s disease mouse model

Song, Y., Dai, C., Shinohara, M., Tung, Y. C., Zhou, S., Huang, W., Seffouh, A., Luo, Y., Willadsen, M., Jiao, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.028 · Cited by 12 · see citing works

Metalloparticle‐Engineered Pickering Emulsion Displaying AAV‐Vectored Vaccine for Enhancing Antigen Expression and Immunogenicity Against Pathogens

Guo, Z., Wu, F., Guo, C., Hu, R., Ou, Y., Zhu, Y., Luo, S., Song, Y., He, P., He, C., et al. (2025) · Advanced Materials · doi:10.1002/adma.202412627 · Cited by 12 · see citing works

SARS‐CoV‐2 Protein Nanoparticle Vaccines Formed In Situ From Lyophilized Lipids

Jiao, Y., Huang, W., Chiem, K., Song, Y., Sun, J., Chothe, S. K., Zhou, S., Luo, Y., Mabrouk, M. T., Ortega, J., et al. (2023) · Small · doi:10.1002/smll.202304534 · Cited by 11 · see citing works

Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC) colonization antigens

Zhou, S., Yu, K. O. A., Mabrouk, M. T., Jahagirdar, D., Huang, W., Guerra, J. A., He, X., Ortega, J., Poole, S., Hall, E. R., et al. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.03.001 · Cited by 11 · see citing works

Antigen Engineering Approaches for Lyme Disease Vaccines

Federizon, J., Lin, Y., & Lovell, J. F. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00167 · Cited by 11 · see citing works

Materials‐based vaccines for infectious diseases

Yang, B., & Wang, H. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1824 · Cited by 10 · see citing works

A broadly applicable protein-polymer adjuvant system for antiviral vaccines

Wang, C., Geng, Y., Wang, H., Ren, Z., Hou, Q., Fang, A., Wu, Q. D., Wu, L., Shi, X., Zhou, M., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00076-4 · Cited by 9 · see citing works

CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits

Koornneef, A., Vanshylla, K., Hardenberg, G., Rutten, L., Strokappe, N. M., Tolboom, J. T. B. M., Vreugdenhil, J., Boer, K. F.-D., Perkasa, A., Blokland, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47492-1 · Cited by 9 · see citing works

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans

Zaric, M., Marini, A., Nielsen, C. M., Gupta, G., Mekhaiel, D., Pham, T., Elias, S. C., Taylor, I. J., de Graaf, H., Payne, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732667 · Cited by 9 · see citing works

Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T‐Cell Responses

He, X., Zhou, S., Quinn, B., Huang, W., Jahagirdar, D., Vega, M., Ortega, J., Long, M. D., Ito, F., Abrams, S. I., et al. (2021) · Advanced Science · doi:10.1002/advs.202103023 · Cited by 8 · see citing works

Nanotoxicological profiles of clinically approved nanoplatforms

Nkanga, C. I. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00458-6 · Cited by 8 · see citing works

Malaria vaccine approaches leveraging technologies optimized in the COVID-19 era

Kanoi, B. N., Maina, M., Likhovole, C., Kobia, F., & Gitaka, J. (2022) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2022.988665 · Cited by 8 · see citing works

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment

Huang, W., Deng, B., Seffouh, A., Ortega, J., Long, C. A., Suresh, R. V., He, X., Miura, K., Lee, S., Wu, Y., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0173-x · Cited by 53 · see citing works

Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association

Federizon, J., Feugmo, C. G. T., Huang, W., He, X., Miura, K., Razi, A., Ortega, J., Karttunen, M., & Lovell, J. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010098 · Cited by 18 · see citing works

Liposomes loaded with P. falciparum merozoite-derived proteins are highly immunogenic and produce invasion-inhibiting and anti-toxin antibodies

Fotoran, W. L., Santangelo, R., Medeiros, M. M., Colhone, M. C., Ciancaglini, P., Barboza, R., Marinho, C. R. F., Stábeli, R. G., & Wunderlich, G. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.045 · Cited by 14 · see citing works

TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25

Thompson, E. A., Ols, S., Miura, K., Rausch, K. M., Narum, D. L., Spångberg, M., Juraska, M., Wille-Reece, U., Weiner, A. J., Howard, R. F., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120692 · Cited by 73 · see citing works

Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability

Mabrouk, M. T., Huang, W., Deng, B., Li-Purcell, N., Seffouh, A., Ortega, J., Atilla‐Gokcumen, G. E., Long, C. A., Miura, K., & Lovell, J. F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119843 · Cited by 24 · see citing works